Michael Moore is an accomplished professional in the field of investor relations and corporate communications, currently serving as Vice President, Investor Relations Officer, and Head of Corporate Communications at Equillium, Inc. since November 2020. Previously, Michael held significant roles including Vice President of Investor Relations and Corporate Communications at Oncolytics Biotech Inc. from February 2017 to June 2020, where responsibilities included enhancing the company’s market position and fostering financial relationships. Michael has also contributed to the National Investor Relations Institute’s San Diego Chapter as a board member from March 2019 to February 2024 and built the US Investor Relations practice for NATIONAL Equicom from June 2005 to February 2017. The earlier career includes positions at Atkins + Associates and FleishmanHillard as an Account Executive. Michael holds a Bachelor of Commerce degree in Finance and Marketing from Mount Allison University.